We demonstrated that both 5-LOX inhibitors antagonized TNF-α-induced IL-6 and MCP-1 expression via inhibition of NF-κB activation in human RA synovial fibroblasts (Figure 8). The gene discussed is NFKB1; the disease is rheumatoid arthritis.